The RDTC has published a new Strategic Insights report on Electronic Repeat Dispensing: understanding the prescribing population & initial barriers to uptake.
Strategic Insight reports are designed to support strategic objectives and planning by Integrated Care System (ICS) leaders. Through the analysis of data and communication with key stakeholders across the ICS, interventions to be undertaken by the ICS are proposed to Integrated Care Boards or associated committees.
This report highlights the benefits of electronic repeat dispensing (eRD) and examines its use at ICS level in the North of England, in order to support systems in identifying where prescribing processes may be further streamlined.
Additional funding from NHS England regional teams has enabled this publication to be made available to non-stakeholders across the North East and Yorkshire, and North West. Further titles in this series will follow, see our work plan for more details.
If you have any queries or comments about this publication, please do not hesitate to contact us at firstname.lastname@example.org.
The Prescribing Support workplan has been updated and is now available on the workplan page. The workplan is updated monthly and includes topics in active development.
Prescribing support newsletters aim to inform readers of work done by the unit and work in progress, to help tailor local work plans and highlight any ‘topical’ issues in prescribing or medicines management.
If you have any suggestions for future topics for the newsletter, then please contact email@example.com
This month’s edition covers how the RDTC can support stakeholder organisations, our recent publications, and the prescribing support workplan. It also has features on post exposure prophylaxis for chickenpox and shingles, the national flu immunisation programme 2022-23, inadvertent oral administration of potassium permanganate, the CVD eLearning programme, WHO changes to the treatment of drug-resistant tuberculosis, and sources of information on menopause and HRT availability.
This workplan is updated monthly and includes topics in active development.
- To suggest a topic or enquire about anything on this workplan, please email us at firstname.lastname@example.org.
- To view a list of recently published items, visit the recent publications page of our website.
- See the last page of the workplan for descriptions of each type of publication, and anticipated publication frequency.
Our new series of monthly formulary amendments have been well received, so we’ve added another set of support documents: formulary assessment tools. These are templates to support local decision making, bringing together NICE guidance, MHRA safety advice, and other relevant high quality advice and guidelines relevant to making decisions for local formularies.
The templates are pre-populated with useful information to reduce duplication of effort, with space for the addition of local information as appropriate. The purpose of the document is to support consistent decision making by formulary groups and APCs.
The first publications in the series cover levomepromazine 6mg tablets and indapamide 1.5mg modified release tablets. This information is produced for use by NHS healthcare professionals and RDTC stakeholders.
Find all of our formulary tools at their own formulary support tools landing page.
Each year the RDTC considers the information published in the SPS Prescribing Outlook series, and from this information highlights developments that are likely to have significant impact on primary care prescribing budgets, over the coming 12 – 15 months.
The RDTC takes the SPS Cost Calculator and aids in filters to calculate totals for each of its stakeholder ICS and CCGs.
A Key Considerations Document accompanies the Cost Calculator detailing the key messages, summarising the current prescribing budget position, and suggesting proposed uplifts to prescribing budgets for the next financial year.
This is supplemented throughout the year with the RDTC Monthly Horizon Scanning series, which provides a more accurate monthly account of the impact of new medicines and recommendations as they publish.
There are five regional versions of this publication. These can all be found on the Annual Horizon Scanning Report page
Monthly Formulary Amendments Documents are a series of new publications from the RDTC for its Stakeholders. These monthly reports list any NICE Technology Appraisals, NICE Guidelines, RMOC Guidance, MHRA Drug Safety Updates, and National Patient Safety Alerts published in the previous calendar month which may have an impact on local formularies and guidelines. This document is for APCs, and formulary committees to ensure formularies remain up to date, and in line with latest NICE guidance and safety information.
It includes a suggested formulary position for APCs/Formulary Committees, together with a summary of any financial/commissioning implications. The purpose of the document is to support consistent decision making by APCs.
This information is produced for use by NHS healthcare professionals and RDTC stakeholders.
These can all be found on the Formulary amendments page
We’re continuing to develop new outputs to best support our stakeholders across the country, and today we’ve published three new bulletins:
You can find all three on the bulletins page. We’d welcome any feedback on these new publications, including input on how often they should be refreshed. Get in touch at email@example.com.